In this study, effects of PLK4 inhibitor Centrinone and lentivirus-mediated PLK4 knockdown on the biological behaviors of AML cell lines were used to investigate roles and mechanisms of PLK4 in the pathology of AML. The gene discussed is PLK4; the disease is acute myeloid leukemia.